Alyeska Investment Group’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-4,677
| Closed | -$576K | – | 490 |
|
|
2017
Q3 | $576K | Buy |
4,677
+84
| +2% | +$10.3K | ﹤0.01% | 410 |
|
|
2017
Q2 | $442K | Sell |
4,593
-140
| -3% | -$13.5K | ﹤0.01% | 411 |
|
|
2017
Q1 | $881K | Sell |
4,733
-55
| -1% | -$10.2K | 0.01% | 425 |
|
|
2016
Q4 | $521K | Buy |
4,788
+402
| +9% | +$43.7K | ﹤0.01% | 427 |
|
|
2016
Q3 | $703K | Buy |
4,386
+386
| +10% | +$61.9K | 0.01% | 412 |
|
|
2016
Q2 | $486K | Buy |
+4,000
| New | +$486K | ﹤0.01% | 397 |
|